Evidence map›Paper›PMID 23833234›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Primary vascularization of allografts governs their immunogenicity and susceptibility to tolerogenesis.

Cavit D Kant, Yoshinobu Akiyama, Katsunori Tanaka, Susan Shea, Sarah E Connolly, Sharon Germana, Henry J Winn, Christian LeGuern, Georges Tocco, Gilles Benichou

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilege.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020
    Article
  4. Emerging role of exosomes in allorecognition and allograft rejection.Current opinion in organ transplantation · 2018
    Review
  5. Article
  6. Persistence of Indirect but Not Direct T Cell Xenoresponses in Baboon Recipients of Pig Cell and Organ Transplants.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2016
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Cavit D KantTransplantation Unit and Transplantation Biology Research Center, Department of Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, MA 02114, USA.
Yoshinobu Akiyama
Katsunori Tanaka
Susan Shea
Sarah E Connolly
Sharon Germana
Henry J Winn
Christian LeGuern
Georges Tocco
Gilles Benichou
Massachusetts General Hospital · USHarvard University · US

Funding

Alloimmunity and Autoimmunity in NOD MiceR01AI054976 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI BENICHOU, GILLES A · 2004 to 2008
$2.1M
Influence of maternal antigens on transplant rejectionR01HD050484 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI BENICHOU, GILLES A · 2005 to 2009
$1.5M
Effects of Lymphangiogenesis Blockade on Skin Allograft RejectionR21AI100278 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI BENICHOU, GILLES A · 2012 to 2013
$370k
Tolerance induction to vascularized skin allograftsR03AI094235 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI BENICHOU, GILLES A · 2011 to 2012
$167k
NIAID NIH HHS R01 AI054976NIAID NIH HHS R03 AI094235NIAID NIH HHS R03AI094235NIAID NIH HHS R21 AI100278NIAID NIH HHS R21AI100278NICHD NIH HHS R01 HD050484
6 · The paper itself

Abstract

We investigated the influence of allograft primary vascularization on alloimmunity, rejection, and tolerance in mice. First, we showed that fully allogeneic primarily vascularized and conventional skin transplants were rejected at the same pace. Remarkably, however, short-term treatment of mice with anti-CD40L Abs achieved long-term survival of vascularized skin and cardiac transplants but not conventional skin grafts. Nonvascularized skin transplants triggered vigorous direct and indirect proinflammatory type 1 T cell responses (IL-2 and IFN-γ), whereas primarily vascularized skin allografts failed to trigger a significant indirect alloresponse. A similar lack of indirect alloreactivity was also observed after placement of different vascularized organ transplants, including hearts and kidneys, whereas hearts placed under the skin (nonvascularized) triggered potent indirect alloresponses. Altogether, these results suggest that primary vascularization of allografts is associated with a lack of indirect T cell alloreactivity. Finally, we show that long-term survival of vascularized skin allografts induced by anti-CD40L Abs was associated with a combined lack of indirect alloresponse and a shift of the direct alloresponse toward a type 2 cytokine (IL-4, IL-10)-secretion pattern but no activation/expansion of Foxp3(+) regulatory T cells. Therefore, primary vascularization of allografts governs their immunogenicity and tolerogenicity.

Indexed as

Skin TransplantationAllograftsAnastomosis, SurgicalAnimalsAntibodies, MonoclonalCD40 LigandCD4-Positive T-LymphocytesGraft Enhancement, ImmunologicGraft SurvivalHeart TransplantationInterferon-gammaLymphocyte ActivationMiceMice, Inbred BALB CMice, Inbred C3HMice, Inbred C57BLAntibodies, MonoclonalCD40 LigandInterferon-gamma

Identifiers

PMID23833234
PMCPMC3735678
OpenAlexW2095906936

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.